Dolasetron (Mesylate hydrate)

Modify Date: 2024-01-02 13:07:07

Dolasetron (Mesylate hydrate) structure	Common Name	Dolasetron (Mesylate hydrate)
	CAS Number	878143-33-0	Molecular Weight	438.49
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₀H₂₆N₂O₇S	Melting Point	178 °C
	MSDS	N/A	Flash Point	N/A

Use of Dolasetron (Mesylate hydrate)

Dolasetron(MDL-73147) is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy.

Name	UNII-U3C8E5BWKR component QTFFGPOXNNGTGZ-BEQIPBGHSA-M
Synonym	More Synonyms

Description	Dolasetron(MDL-73147) is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy.
Related Catalog	Signaling Pathways >> GPCR/G Protein >> 5-HT Receptor Signaling Pathways >> Neuronal Signaling >> 5-HT Receptor Research Areas >> Others
References	[1]. Faria C, et al. Outcomes Associated with 5-HT3-RA Therapy Selection in Patients with Chemotherapy-Induced Nausea and Vomiting: A Retrospective Claims Analysis. Am Health Drug Benefits. 2014 Jan;7(1):50-8. [2]. Schwartzberg L, et al. Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV). Support Care Cancer. 2014 Feb;22(2):469-77.

Description

Dolasetron(MDL-73147) is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy.

Related Catalog

Signaling Pathways >> GPCR/G Protein >> 5-HT Receptor

Signaling Pathways >> Neuronal Signaling >> 5-HT Receptor

Research Areas >> Others

References